Lucid Diagnostics Inc (LUCD) support and resistance · rev $2.7M
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
This page maps Lucid Diagnostics Inc (LUCD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LUCD revenue for 2026-06-30 was $2.7M. Net income was -$25.6M. LUCD currently screens at market cap $123.3M.
LUCD currently screens at market cap $123.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LUCD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LUCD quote page for the session range and the stock page for the full model.
Not investment advice.